Site Map Press Room Careers
Financial
Financial Results
Financial Highlights
Annual Reports
Business Drivers
Investors
Contact Person
Frequently Asked Questions
 Financial Results
Financial Results For The Year Ended March 31, 2008
  (Rs.in Mio)

Particulars

 Unaudited Results Audited Stand alone Results Audited Consolidated Results
Nine Months Ended Three Months Ended The Year Ended The Year Ended
31.12.2007 31.03.2008 31.03.2007 31.03.2008 31.03.2007 31.03.2008 31.03.2007
Sales/Income from Operations(including excise duty) 16,911 6,601 5,328 23,511 19,797 25,523 22,241
Less: Excise Duty 887 277 220 1,164 1,012 1,164 1,012
Net Sales/Income from Operations 16,023 6,324 5,108 22,347 18,786 24,359 21,229
Other Income 1,092 89 152 1,181 390 943 493
Total Income 17,115 6,413 5,260 23,528 19,176 25,302 21,722
Expenditure
a. (Increase)/Decrease in Stock (759) 412 -161 (347) -744 -712 -891
b. Material Consumed 10,309 3,446 2,955 13,755 11,924 12,612 11,756
c. Purchase of traded goods 122 -4 400 118 481 1,615 1,351
d. Staff Cost 1,099 388 320 1,487 1,129 1,930 1,504
e. Depreciation/Amortisation 553 193 263 746 718 1,004 997
f. Other Expenditure 3,086 1,074 942 4,160 3,169 5,504 4,487
Total Expenditure 14,410 5,509 4,719 19,918 16,677 21,952 19,205
Profit before interest & tax 2,705 904 541 3,609 2,499 3,350 2,518
Interest (net) 117 44 30 161 187 432 454
Profit from Ordinary Activities before tax 2,588 860 511 3,448 2,312 2,918 2,064
Provision for Taxation
a. Current Tax 428 56 22 484 181 479 203
b. MAT Credit Entitlement - - -91 - -146 - -146
c. Deferred Tax 9 43 -234 52 -41 52 -41
d. Fringe Benefit Tax (net of recovery) 4 1 1 5 4 5 4
e. Tax adjustments of previous years - - 32 - 22 - 22
Total Tax 441 99 -270 541 21 536 44
Profit before Minority Interest 2,147 761 781 2,907 2,291 2,382 2,021
Minority Interest - 34 -110
Net Profit for the period 2,147 761 781 2,907 2,291 2,416 1,911
Paid-up Equity Share Capital 2,688.26 2,667.43 2,688.26 2,667.43
(Face value Rs. 5 per share)
Reserves excluding Revaluation Reserve 119,372 90,263 109,714 85,932
Basic Earnings per share before & after Extraordinary items (Rs.) 40.06 14.15 14.64 54.21 42.98 44.46 37.7
Diluted Earnings per sharebefore & after Extraordinary items (Rs.) 31.82 11.25 11.56 43.07 34.51 35.33 30.27
Aggregate of non-promoters Shareholding
a. Number of Shares 24,049,036 23,636,405 24,049,036 23,636,405
b. Percentage of Shareholding 44.73 44.31 44.73 44.31
Notes:
1. The above audited financial results as reviewed by the Audit Committee have been approved by the Board at its meeting held on June 18, 2008.
2. The consolidated financial results include the results of subsidiary companies and 50:50 joint venture companies accounted in accordance with accounting principles as defined in Accounting Standards 21 and 27 issued by the Institute of Chartered Accountants of India.
3. The Board recommends dividend @ 65% on the equity share capital of the Company i.e. Rs.3.25 per share subject to approval of members.
4. Keeping in view the Company's business model of vertical integration, the management reviewed the reporting of its financial results under one segment and accordingly the Company reported its entire results under one segment viz., 'Pharmaceutical Products'.
5. FOB value of exports is Rs.133,94.9 millions (Previous year: Rs.109,68.3 millions).
6. Investor complaints pending at the beginning of the quarter: Nil, received: 49, resolved: 49 and lying unresolved at the end of the quarter Nil.
7. Premium on redemption of USD 255.5 million zero coupon Foreign Currency Convertible Bonds is contingent in nature, the outcome of which is dependent on uncertain future events.
8. During the quarter, the Company has formed new step-down subsidiaries viz., Agile Pharma (Malta) Ltd., Aurobindo Pharma (Italia) S.r.l, Laboratorios Aurobindo Sociedad Limitada, Spain and Aurobindo Pharma (Ireland) Limited.
9. Figures for the Previous Year have been rearranged/regrouped wherever necessary.
    For and on behalf of the Board
Place: Hyderabad    K.Nityananda Reddy
Date : June 18, 2008   Managing Director
Site Map Press Room Careers